Descriptor English: | 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | ||||||
Descriptor Spanish: |
Ácido 3-piridinacarboxílico, 1,4-dihidro-2,6-dimetil-5-nitro-4-(2-(trifluorometil)fenil)-, Éster Metílico
| ||||||
Descriptor Portuguese: | Éster Metílico do Ácido 3-Piridinacarboxílico, 1,4-Di-Hidro-2,6-Dimetil-5-Nitro-4-(2-(Trifluormetil)fenil) | ||||||
Descriptor French: | 4-(2-(Trifluorométhyl)phényl)-2,6-diméthyl-5-nitro-1,4-dihydro-nicotinate de méthyle | ||||||
Entry term(s): |
BK 8644 BK-8644 BK8644 Bay K 8644 Bay K8644 Bay R 5417 Bay R5417 Bay-K-8644 Bay-K-8644, (+)-Isomer Bay-K-8644, (+-)-Isomer Bay-K-8644, (-)-Isomer Bay-K8644 Bay-R-5417 BayK8644 BayR5417 R5417, Bay |
||||||
Tree number(s): |
D03.383.725.203.600 D03.383.725.547.900 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D001498 | ||||||
Scope note: | A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. It is used primarily as a research tool. |
||||||
Annotation: | a calcium channel agonist |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Calcium Channel Agonists |
||||||
Registry Number: | 71145-03-4 | ||||||
CAS Type 1 Name: | 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester | ||||||
Previous Indexing: |
Nifedipine/analogs & derivatives (1975-1986) Pyridines (1966-1974) |
||||||
Public MeSH Note: | 87 |
||||||
History Note: | 87 |
||||||
DeCS ID: | 23220 | ||||||
Unique ID: | D001498 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1987/01/01 | ||||||
Date of Entry: | 1986/06/02 | ||||||
Revision Date: | 2016/05/27 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
- Preferred
Bay-R-5417
- Narrower
Bay-K-8644, (+-)-Isomer
- Narrower
Bay-K-8644, (-)-Isomer
- Narrower
Bay-K-8644
- Narrower
Bay-K-8644, (+)-Isomer
- Narrower
Concept UI |
M0002232 |
Scope note | A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. It is used primarily as a research tool. |
Preferred term | 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester |
Concept UI |
M0002233 |
Preferred term | Bay-R-5417 |
Entry term(s) |
Bay R 5417 Bay R5417 BayR5417 R5417, Bay |
Concept UI |
M0330828 |
Preferred term | Bay-K-8644, (+-)-Isomer |
Concept UI |
M0330829 |
Preferred term | Bay-K-8644, (-)-Isomer |
Concept UI |
M0464447 |
Preferred term | Bay-K-8644 |
Entry term(s) |
BK 8644 BK-8644 BK8644 Bay K 8644 Bay K8644 Bay-K8644 BayK8644 |
Concept UI |
M0330830 |
Preferred term | Bay-K-8644, (+)-Isomer |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey